Abstract
Patients with non-functioning pituitary adenomas (NFPAs) are followed-up with serial endocrine, ophthalmologic and radiological assessment. There is a lack of evidence based guidance regarding the frequency and duration of radiological assessment during follow-up. We retrospectively analysed the details of follow-up radiological scanning in a cohort of patients diagnosed with NFPAs in an attempt to devise a rational and cost effective scanning schedule for use in routine clinical practice. 49 patients were identified using the hospital endocrine register. A detailed review of the case notes and follow up scans was undertaken. The data was analysed using descriptive statistics and Kaplan–Meier survival analysis using SPSS ver 13.0 (SPSS Inc. Chicago, IL). The time in which the tumor size in the followed up patients reached a state of ‘no change’ which persisted for at least two further scans was calculated. 41 patients, followed up for a median duration of 70 months were ultimately analysed. 33 patients had surgery while eight were conservatively managed. The time taken by 50% of tumors to achieve a steady state of ‘no change’ in tumor size on scans was 30 months. 90% of tumours achieved this state in 88 months. Surgical management did not significantly influence the time required to attain the steady state on a Kaplan–Meier analysis (Log rank test P = 0.06). NFPAs need extended follow-up since late recurrences after treatment are known. Routine radiologic follow up may be uneconomical after the steady state is achieved. Regular Goldmann perimetry beyond this time may be of greater use in selecting patients who actually need repeat surgical debulking. This method of follow up is likely to be more cost effective and reduce the number of scans performed.
Similar content being viewed by others
References
Jaffe CA (2006) Clinically non-functioning pituitary adenoma. Pituitary 9:317–321. doi:10.1007/s11102-006-0412-9
Jane JA Jr, Laws ER Jr (2002) Surgical management of pituitary adenomas. Singapore Med J 43:318–323
McComb DJ, Ryan N, Horvath E, Kovacs K (1983) Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 107:488–491
Harris PE, Afshar F, Coates P et al (1989) The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. Q J Med 71:417–427
Dekkers OM, Hammer S, de Keizer RJ et al (2007) The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol 156:217–224. doi:10.1530/eje.1.02334
Dekkers OM, Pereira AM, Roelfsema F et al (2006) Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:1796–1801. doi:10.1210/jc.2005-2552
Lohmann T, Trantakis C, Biesold M et al (2001) Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline. Pituitary 4:173–178. doi:10.1023/A:1015366923810
Hayashi M, Izawa M, Hiyama H et al (1999) Gamma Knife radiosurgery for pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl 1):111–118. doi:10.1159/000056446
Muacevic A, Uhl E, Wowra B (2004) Gamma knife radiosurgery for nonfunctioning pituitary adenomas. Acta Neurochir Suppl (Wien) 91:51–54
Brada M, Rajan B, Traish D et al (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38:571–578. doi:10.1111/j.1365-2265.1993.tb02137.x
Bradley KM, Adams CB, Potter CP et al (1994) An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clin Endocrinol (Oxf) 41:655–659. doi:10.1111/j.1365-2265.1994.tb01832.x
Breen P, Flickinger JC, Kondziolka D, Martinez AJ (1998) Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 89:933–938
Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y (2003) A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 149:123–127. doi:10.1530/eje.0.1490123
Soto-Ares G, Cortet-Rudelli C, Assaker R et al (2002) MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas. Eur J Endocrinol 146:179–186. doi:10.1530/eje.0.1460179
Turner HE, Stratton IM, Byrne JV, Adams CB, Wass JA (1999) Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation––a follow-up study. Clin Endocrinol (Oxf) 51:281–284. doi:10.1046/j.1365-2265.1999.00865.x
Ferrante E, Ferraroni M, Castrignano T et al (2006) Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol 155:823–829. doi:10.1530/eje.1.02298
Ciric I, Mikhael M, Stafford T, Lawson L, Garces R (1983) Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 59:395–401
Flickinger JC, Nelson PB, Martinez AJ, Deutsch M, Taylor F (1989) Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer 63:2409–2414. doi:10.1002/1097-0142(19890615)63:12>2409::AID-CNCR2820631206>3.0.CO;2-M
Grigsby PW, Simpson JR, Emami BN, Fineberg BB, Schwartz HG (1989) Prognostic factors and results of surgery and postoperative irradiation in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys 16:1411–1417
Park P, Chandler WF, Barkan AL et al (2004) The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 55:100–106. doi:10.1227/01.NEU.0000126885.71242.D7 discussion 106-107
Woollons AC, Hunn MK, Rajapakse YR et al (2000) Non-functioning pituitary adenomas: indications for postoperative radiotherapy. Clin Endocrinol (Oxf) 53:713–717. doi:10.1046/j.1365-2265.2000.01153.x
Greenman Y, Ouaknine G, Veshchev I et al (2003) Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf) 58:763–769. doi:10.1046/j.1365-2265.2003.01784.x
Lillehei KO, Kirschman DL, Kleinschmidt-DeMasters BK, Ridgway EC (1998) Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Neurosurgery 43:432–438. doi:10.1097/00006123-199809000-00020 discussion 438–439
Donovan LE, Corenblum B (1995) The natural history of the pituitary incidentaloma. Arch Intern Med 155:181–183. doi:10.1001/archinte.155.2.181
Reincke M, Allolio B, Saeger W, Menzel J, Winkelmann W (1990) The ‘incidentaloma’ of the pituitary gland. Is neurosurgery required? JAMA 263:2772–2776. doi:10.1001/jama.263.20.2772
Alameda C, Lucas T, Pineda E et al (2005) Experience in management of 51 non-functioning pituitary adenomas: indications for post-operative radiotherapy. J Endocrinol Invest 28:18–22
Grigsby PW, Simpson JR, Fineberg B (1989) Late regrowth of pituitary adenomas after irradiation and/or surgery. Hazard function analysis. Cancer 63:1308–1312. doi:10.1002/1097-0142(19890401)63:7<1308::AID-CNCR2820630714>3.0.CO;2-Y
Popovic V, Damjanovic S, Micic D et al (1998) Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin Endocrinol (Oxf) 49:441–445. doi:10.1046/j.1365-2265.1998.00536.x
Feldkamp J, Santen R, Harms E et al (1999) Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas––results of a prospective study. Clin Endocrinol (Oxf) 51:109–113. doi:10.1046/j.1365-2265.1999.00748.x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coulter, I.C., Mukerji, N., Bradey, N. et al. Radiologic follow-up of non-functioning pituitary adenomas: rationale and cost effectiveness. J Neurooncol 93, 157–163 (2009). https://doi.org/10.1007/s11060-009-9901-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-009-9901-9